Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin - PubMed (original) (raw)

PMID: 372242
PMCID: PMC371983
DOI: 10.1172/JCI109332

Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin

E A Jaffe et al. J Clin Invest. 1979 Mar.

Abstract

Endothelial cells synthesize prostacyclin (PGI(2)), an unstable prostaglandin that inhibits platelet aggregation and serotonin release. Because cyclooxygenase, which is necessary for synthesis of PGI(2), is inactivated by aspirin, we examined the effect of aspirin on PGI(2) production by cultured human endothelial cells. Endothelial cells synthesize PGI(2) (20.1+/-7.2 ng/10(6) cells, mean+/-SD) when stimulated with 20 muM sodium arachidonate for 2 min. PGI(2) production is inhibited by low-dose aspirin (5 muM); the t((1/2)) of inactivation is 6.0+/-1.3 min (mean+/-SEM, n = 3). Thus, endothelial cell cyclooxygenase is as sensitive to aspirin as the enzyme in platelets. After 1 h incubation with aspirin, endothelial cell PGI(2) production was inhibited 50% by 2.1+/-0.4 muM aspirin and was inhibited 90% by 6.2+/-0.9 muM aspirin (mean+/-SEM, n = 4). When endothelial cells were incubated with 100 muM aspirin, washed, and recultured, their ability to synthesize PGI(2) returned to control levels in 35.6+/-1.0 h (mean+/-SEM, n = 4). Recovery of endothelial PGI(2) production after aspirin depended on de novo protein synthesis because treatment with cycloheximide (3 mug/ml) inhibited recovery by 92%.These results indicate that although endothelial cell cyclooxygenase in vitro is inhibited by low concentrations of aspirin, endothelial cells rapidly resynthesize their cyclooxygenase after the aspirin is removed. This rapid resynthesis of cyclooxygenase lessens the likelihood that aspirin used in clinical doses promotes thrombosis.

PubMed Disclaimer

Cited by

Aspirin in cardiovascular disease.
Reilly IA, FitzGerald GA. Reilly IA, et al. Drugs. 1988 Feb;35(2):154-76. doi: 10.2165/00003495-198835020-00005. Drugs. 1988. PMID: 3281822 Review.
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.
Moncada S. Moncada S. Br J Pharmacol. 1982 May;76(1):3-31. doi: 10.1111/j.1476-5381.1982.tb09186.x. Br J Pharmacol. 1982. PMID: 7044460 Free PMC article. Review. No abstract available.
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd, Lawson JA, Brash AR. FitzGerald GA, et al. J Clin Invest. 1983 Mar;71(3):676-88. doi: 10.1172/jci110814. J Clin Invest. 1983. PMID: 6338043 Free PMC article.
Effect of hematin on endothelial cells and endothelial cell-platelet interactions.
Neely SM, Gardner DV, Green D, Ts'ao CH. Neely SM, et al. Am J Pathol. 1984 Jun;115(3):390-6. Am J Pathol. 1984. PMID: 6375390 Free PMC article.
A regimen for low-dose aspirin?
Hanley SP, Bevan J, Cockbill SR, Heptinstall S. Hanley SP, et al. Br Med J (Clin Res Ed). 1982 Nov 6;285(6351):1299-302. doi: 10.1136/bmj.285.6351.1299. Br Med J (Clin Res Ed). 1982. PMID: 6812685 Clinical Trial.

References

1. Prostaglandins. 1977 Mar;13(3):377-88 - PubMed
1. Lancet. 1978 Jun 17;1(8077):1307 - PubMed
1. Prostaglandins. 1977 Mar;13(3):389-97 - PubMed
1. J Clin Invest. 1978 Feb;61(2):314-9 - PubMed
1. J Clin Invest. 1978 Nov;62(5):923-30 - PubMed

Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin - PubMed (original) (raw)